| 4916 |
Centers for Disease Control and Prevention |
Html |
en |
Overview of a Pandemic - Detection of the 2009 H1N1 Virus |
null |
| expert assessments | 0.246465 |
| respiratory illness outbreaks | 0.517136 |
| Retrospective evidence | 0.326351 |
| World Health Organization | 0.443124 |
| scientific criteria | 0.248518 |
| CDC Seasonal Flu | 0.643148 |
| novel influenza | 0.406623 |
| available evidence | 0.293437 |
| influenza pandemic alert | 0.92733 |
| human flu virus | 0.731243 |
|
| English language content | 0.544793 |
| National Public Health | 0.468582 |
| H1N1 virus | 0.373547 |
| stand-alone Web document | 0.512202 |
| Global pandemic | 0.593937 |
| 2009 influenza pandemic | 0.961333 |
| reference purposes | 0.295017 |
| PowerPoint presentation | 0.274438 |
| Section 508-accessible version | 0.493981 |
|
CLICK HERE |
| 5885 |
Centers for Disease Control and Prevention |
Html |
en |
Cyclopentadiene - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6588 |
Centers for Disease Control and Prevention |
Html |
en |
Notifiable Diseases and Mortality Tables - January 27, 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| provisional 4-week totals | 0.784874 |
| Mortality Tables | 0.477141 |
| equine encephalitis virus | 0.622274 |
| Mortality Weekly Report | 0.477882 |
| Viral hemorrhagic fever¶¶¶ | 0.460176 |
| provisional cases | 0.69277 |
| Hantavirus pulmonary syndrome§ | 0.463779 |
| Staphylococcus aureus§ | 0.461394 |
| New York City | 0.44693 |
| acute hepatitis | 0.500723 |
| 2011-12 influenza season | 0.477091 |
| noncholera Vibrio species | 0.459928 |
| influenza A virus | 0.484096 |
| National Center | 0.584399 |
| CDC Home CDC | 0.487069 |
| Hemolytic uremic syndrome | 0.465607 |
| California serogroup virus | 0.508464 |
| meningococcal disease | 0.543934 |
| historical data | 0.543499 |
| Influenza Division | 0.458349 |
| Ñ?ЛП
Notifiable Diseases | 0.543592 |
| Cumulative year-to-date counts | 0.456713 |
| 2009 pandemic | 0.51365 |
| Respiratory Diseases | 0.449763 |
|
| NN | 0.452598 |
| United States | 0.946881 |
| Vancomycin-resistant Staphylococcus aureus§ | 0.456943 |
| novel influenza | 0.551221 |
| I. Provisional cases | 0.528175 |
| 5-year weekly average†| 0.48599 |
| notifiable diseases | 0.854585 |
| Vancomycin-intermediate Staphylococcus aureus§ | 0.456238 |
| Eastern equine encephalitis | 0.477622 |
| pandemic influenza | 0.523167 |
| Influenza-associated pediatric mortality§ | 0.457008 |
| viral hemorrhagic fever | 0.449068 |
| New York | 0.459829 |
| Western equine encephalitis | 0.476934 |
| Polio virus Infection | 0.468822 |
| Total case counts | 0.449998 |
| notifiable disease reports | 0.760722 |
| current 4-week total | 0.48863 |
| Vector-Borne Infectious Diseases | 0.464365 |
| Chlamydia trachomatis infection | 0.447967 |
| TABLE I. | 0.480251 |
| dengue hemorrhagic fever | 0.45224 |
| subsequent 4-week periods | 0.473894 |
| West Nile virus | 0.464404 |
|
CLICK HERE |
| 6936 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Multistate Outbreak of Postprocedural Fungal Endophthalmitis Associated with a Single Compounding Pharmacy - United States, March-April 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| Rachel Smith | 0.619126 |
| sterile preparations | 0.657014 |
| pars plana vitrectomies | 0.624771 |
| MMWR HTML versions | 0.623084 |
| professional ophthalmology societies | 0.622882 |
| electronic PDF version | 0.61732 |
| invasive ophthalmic procedure | 0.626815 |
| state health departments | 0.658871 |
| probable cases | 0.614592 |
| States Pharmacopeia-National Formulary | 0.624453 |
| intravitreal injections | 0.640976 |
| ongoing investigation | 0.623406 |
| incarnatum-equiseti species | 0.637456 |
| BBG dye | 0.807755 |
| local health alerts | 0.670346 |
| Franck | 0.720512 |
| triamcinolone-containing products | 0.701262 |
| York City Dept | 0.637181 |
| intravitreal injection | 0.70771 |
| postprocedure adverse events | 0.629096 |
| mold Bipolaris hawaiiensis | 0.62855 |
| Angeles County Department | 0.648725 |
| ambulatory surgical center | 0.640316 |
| original paper copy | 0.611501 |
|
| sterile compounded products | 0.748392 |
| current investigative findings | 0.628737 |
| root cause | 0.620976 |
| different compounding pharmacy | 0.618867 |
| Public Health | 0.970385 |
| original MMWR paper | 0.622174 |
| U.S. Government Printing | 0.618089 |
| genetic sequencing | 0.637618 |
| possible fungal infection | 0.640157 |
| United States Pharmacopeia | 0.62804 |
| F. incarnatum-equiseti species | 0.632113 |
| Christina Mikosz | 0.619469 |
| local health departments | 0.681291 |
| Kavita K. Trivedi | 0.620682 |
| Career Epidemiology Field | 0.611471 |
| FDA MedWatch alerts | 0.629197 |
| adverse events | 0.68515 |
| ClinMicroNet microbiology laboratories | 0.621265 |
| Angeles County Dept | 0.641264 |
| Public Health Preparedness | 0.666009 |
| Indiana State Dept | 0.646402 |
| repeat ophthalmic surgery | 0.630102 |
| Fusarium incarnatum-equiseti species | 0.636935 |
| available isolates | 0.645391 |
|
CLICK HERE |
| 8258 |
Centers for Disease Control and Prevention |
Html |
en |
Normal Joint Range of Motion Study |
null |
| statutorily based requirements | 0.82118 |
| elbow | 0.535852 |
| CDC | 0.622541 |
| joint mobility | 0.921855 |
| data | 0.760287 |
| joints | 0.766556 |
| Wang | 0.532467 |
| Soucie JM | 0.702684 |
| disorders | 0.665369 |
| loss | 0.533018 |
| Data Use Restrictions | 0.700122 |
| download | 0.561303 |
| Disease Control | 0.675969 |
| health statistical reporting | 0.811715 |
| joint range | 0.715276 |
| comparison studies | 0.674187 |
| normal range | 0.851686 |
| Von Willebrand Disease | 0.90059 |
| joint disease results | 0.904026 |
| direct identifiers | 0.673735 |
| important information | 0.839163 |
| intentional identification | 0.677084 |
| baseline | 0.581021 |
| motion measurements | 0.706041 |
| physical conditions | 0.688943 |
|
| joint bleeding | 0.849423 |
| Statistical Analysis Software | 0.825868 |
| Sample Tables | 0.674456 |
| following table | 0.683359 |
| confidentiality | 0.535593 |
| public use dataset | 0.740676 |
| Roach KE | 0.697352 |
| general population | 0.688308 |
| data files | 0.694728 |
| identity | 0.552821 |
| Denney | 0.54295 |
| data subjects | 0.688214 |
| ankle | 0.533297 |
| reference values | 0.851222 |
| assurances | 0.547727 |
| Haemophilia | 0.544449 |
| disclosure | 0.533422 |
| sex | 0.532471 |
| people | 0.665504 |
| Health Service Act | 0.817283 |
| chronic joint disease | 0.900406 |
| confidence intervals | 0.691493 |
| time | 0.570089 |
| Hemophilia Treatment Center | 0.857788 |
|
CLICK HERE |
| 8900 |
Centers for Disease Control and Prevention |
Html |
en |
Malaria - Travelers - Choosing a Drug to Prevent Malaria |
Education and information regarding choosing a drug to prevent malaria, including a list of all available drugs and reasons for taking or not taking a certain drug. |
| rheumatologic conditions | 0.392761 |
| weekly medication | 0.473447 |
| comparable efficacy | 0.407328 |
| drug needs | 0.46686 |
| drug-drug interactions | 0.40167 |
| pregnant women | 0.473062 |
| normal G6PD level | 0.4553 |
| G6PD deficiency | 0.443444 |
| insecticide-treated bednet | 0.410726 |
| drug allergies | 0.403696 |
| alphabetical order | 0.403395 |
| certain psychiatric conditions | 0.453646 |
| mefloquine resistance | 0.497072 |
| glucose-6-phosphatase dehydrogenase | 0.387492 |
| decision process | 0.400568 |
| insect repellent | 0.403533 |
| medical contraindications | 0.404365 |
| Yellow Book | 0.40283 |
| malaria differ | 0.41746 |
| cardiac conduction abnormalities | 0.458503 |
| seizure disorder | 0.388218 |
| effective medicine | 0.397081 |
| shorter trips | 0.471861 |
| following table | 0.400597 |
| good choice | 0.977934 |
|
| long pants | 0.401752 |
| upset stomach | 0.485209 |
| long duration | 0.405811 |
| different medicine | 0.39829 |
| P. vivax | 0.461266 |
| different drugs | 0.396125 |
| personal protective measures | 0.482787 |
| daily medicine | 0.561869 |
| severe renal impairment | 0.475026 |
| additional medicine | 0.475526 |
| vaginal yeast infections | 0.458691 |
| considerable sun exposure | 0.457113 |
| medicine | 0.667512 |
| short duration | 0.582285 |
| people | 0.778207 |
| long trips | 0.461726 |
| malaria transmission | 0.589672 |
| trips | 0.48935 |
| antimalarial drug | 0.414227 |
| mosquito-free setting | 0.405141 |
| last-minute travelers | 0.868921 |
| country-specific tables | 0.408285 |
| Pediatric tablets | 0.398831 |
| fresh water | 0.387441 |
|
CLICK HERE |
| 10071 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Features -Birth Defects Findings Terms - NCBDDD |
null |
| general public | 0.55553 |
| birth conditions | 0.567925 |
| findings | 0.510342 |
| body | 0.519797 |
| individuals | 0.510282 |
| research | 0.519927 |
| preferred phrase | 0.61411 |
| mental retardation | 0.555503 |
| birth disorders | 0.569177 |
| Birth Defects Res | 0.68686 |
| common phrase | 0.605842 |
| function | 0.519815 |
| previous studies | 0.557064 |
| Birth Defects Terminology | 0.686457 |
| Petersen EE | 0.55682 |
| family members | 0.555907 |
| A. Public Perception | 0.59822 |
| article | 0.520036 |
| best serve people | 0.591821 |
| respondents | 0.584709 |
| phrase | 0.646688 |
| publicly accepted term | 0.5979 |
| negative view | 0.5558 |
| intellectual disability | 0.554179 |
| journal Birth Defects | 0.728178 |
|
| adverse pregnancy outcomes | 0.606314 |
| proportion | 0.513272 |
| congenital malformations | 0.563179 |
| congenital anomalies | 0.561329 |
| nationally representative survey | 0.601047 |
| Mai CT | 0.553097 |
| common terminology | 0.554099 |
| negative connotation | 0.565456 |
| epub | 0.513804 |
| new study online | 0.616633 |
| nationally representative sample | 0.611252 |
| special issue | 0.561835 |
| summary | 0.511138 |
| Birth Defects Terminology. | 0.726893 |
| special needs | 0.555772 |
| visit www.cdc.gov/birthdefects | 0.551871 |
| suitable phrase | 0.596832 |
| support groups | 0.550865 |
| concerns | 0.5208 |
| birth defects | 0.954073 |
| well-recognized phrase | 0.620585 |
| Public Perception | 0.612376 |
| health groups | 0.55361 |
| structure | 0.519828 |
|
CLICK HERE |
| 11527 |
Centers for Disease Control and Prevention |
Html |
en |
NCIRD | About Division of Bacterial Diseases |
null |
| briefing documents | 0.240304 |
| DBD programs | 0.327139 |
| vaccine-preventable disease | 0.643781 |
| policy matters | 0.223914 |
| respiratory bacterial diseases | 0.943723 |
| Accelerate development | 0.492172 |
| bacterial vaccines | 0.718602 |
| Page | 0.235641 |
| outbreak investigations | 0.255669 |
| adapt existing methods | 0.409897 |
| laboratory science | 0.269085 |
| vaccine-preventable disease issues | 0.596505 |
| epidemiologic | 0.235726 |
| policy implications | 0.226633 |
| pathogen characterization | 0.277659 |
| new methods | 0.219418 |
| critical role | 0.265305 |
|
| statistical applications | 0.220442 |
| National Center | 0.266257 |
| interested stakeholders | 0.227551 |
| outbreak response | 0.299461 |
| vaccine development | 0.263765 |
| ongoing surveillance | 0.222533 |
| bacterial pathogens | 0.498505 |
| Provide statistical consultation | 0.398411 |
| legislative proposals | 0.230827 |
| bacterial respiratory | 0.720707 |
| laboratory diagnosis | 0.265192 |
| laboratory research studies | 0.763635 |
| ongoing Division activities | 0.391125 |
| primary contact | 0.238353 |
| Respiratory Diseases | 0.445431 |
| congressional testimony | 0.23405 |
| vaccine-preventable diseases | 0.418715 |
|
CLICK HERE |
| 14272 |
Centers for Disease Control and Prevention |
Html |
es |
Sífilis y los hombres que tienen relaciones sexuales con hombres - Hoja informativa de los CDC |
Sífilis y los hombres que tienen relaciones sexuales con hombres: Hoja informativa de los CDC |
| Archivo Apple Quicktime | 0.629398 |
| Archivo Microsoft PowerPoint | 0.651972 |
| Archivo Adobe PDF | 0.625715 |
| alto riesgo | 0.55208 |
| Estados Unidos | 0.763632 |
| Archivo Microsoft | 0.941593 |
| Archivo Microsoft Word | 0.648381 |
|
| múltiples parejas | 0.554742 |
| medicamentos correctos | 0.529695 |
| largo plazo | 0.796786 |
| Archivo Zip Comprimido | 0.625166 |
| única forma | 0.522516 |
| tantos sÃntomas | 0.547882 |
| Archivo Microsoft Excel | 0.622424 |
|
CLICK HERE |
| 15391 |
Centers for Disease Control and Prevention |
Html |
en |
Changes in Density of On-Premises Alcohol Outlets and Impacton Violent Crime, Atlanta, Georgia, 1997-2007 |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| alcohol outlet exposure | 0.352574 |
| violent crime | 0.597485 |
| on-premises alcohol outlet | 0.209616 |
| on-premises retail alcohol | 0.325513 |
| high alcohol outlet | 0.257473 |
| alcohol outlet density | 0.988327 |
|
| retail alcohol outlets | 0.406802 |
| outlet exposure index | 0.223671 |
| annual alcohol outlet | 0.214937 |
| excessive alcohol consumption | 0.315465 |
| alcohol outlets | 0.499947 |
|
CLICK HERE |